| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |